Nathan Shapiro, MD
Emergency Medicine · Boston, MANPI 1063561140
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $292,037 of the $311,045 with a category attached, or 93.9%. Prenosis Inc. accounts for 80.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $137,768, 7.5 times the $18,397 reported in 2019. Among emergency medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $7776.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Prenosis Inc.$250K
- Baxter Healthcare$24K
- Lumos Diagnostics, Inc.$10K
- CSL Behring$8K
- AbbVie$7K
- Beckman Coulter, Inc.$7K
- plus $7K from 4 others
Across 37 payments — averaging $21,026 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Baxter Healthcare$239K
- Biomerieux Inc$187K
- Rapid Pathogen Screening, Inc.$178K
- Regeneron$115K
- Siemens Medical Solutions USA, Inc.$42K
- Octapharma USA, Inc.$17K
Across 1 payment — averaging $16,326 each. An ownership or investment interest held by the physician or an immediate family member.
- Prenosis Inc.$16K
What the payments were for
- Consulting fees$292,03794%
- Speaking & faculty fees$8,7003%
- Travel & lodging$9,7483%
- Food & beverage$5600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Prenosis Inc. | 22 | $249,623 |
| Baxter Healthcare | 7 | $23,746 |
| Lumos Diagnostics, Inc. | 3 | $9,690 |
| CSL Behring | 1 | $7,770 |
| AbbVie | 1 | $6,900 |
| Beckman Coulter, Inc. | 1 | $6,750 |
| Roche Diagnostics International Ltd | 1 | $5,700 |
| Regeneron | 1 | $584 |
| Novartis | 2 | $270 |
| Octapharma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sepsis ImmunoScore TM$126,138
- Sepsis ImmunoScore$123,330
- Fluid Systems - Non Prod Related$23,624
- FebriDx$9,690
- Kcentra$7,770
How this compares
$311,045 in reported general payments places this provider in the 95th percentile of 1,429 emergency medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $371 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Boston
- Christopher GilliganBoston$1M
- Joshua GoldsteinBoston$234K
- Adaira LandryBoston$211K
- Elissa PerkinsBoston$205K
- Christopher BaughBoston$146K
- Chanel FischettiBoston$71K
- Christopher KabrhelBoston$54K
- Jarone LeeBoston$34K
- Scott WeinerBoston$18K
- Adam LandmanBoston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.